Navigation Links
Medicomp fills healthcare gap, introducing new wireless cardiac technology
Date:8/9/2013

MELBOURNE, Fla., Aug. 9, 2013 /PRNewswire-iReach/ -- Medicomp, Inc. (www.medicompinc.com), introduces the SAVI Air, the only Wireless Event Monitor to offer beat-to-beat analysis of the entire ECG, a patented feature previously unavailable to healthcare.

(Photo: http://photos.prnewswire.com/prnh/20130809/MN61669)

"What makes the SAVI Air wireless event monitor truly stand out is our Diogenes algorithm, which resides on our entire line of monitors and is widely regarded as the most advanced artificial intelligence technology in the industry," says Dan Balda, M.D., Medicomp CEO.

Prior to the release of the SAVI Air, wireless event monitors relied on algorithms that could only analyze limited aspects of the ECG, therefore increasing the risk of missing significant arrhythmias. 

The Diogenes algorithm is the only ambulatory cardiac monitoring technology to offer Rate, Rhythm, Morphology, and P-wave analysis. "No other company's monitors provide this same complete analysis," says Dr. Balda. "We know because we have the patent."

The SAVI Air provides all the benefits and convenience of a wireless event monitor with the highest clinical yield available allowing for faster diagnosis and treatment.

Physicians no longer have to compromise on different standards of care with SAVI Air added to Medicomp's product line. Physicians now have the ability to choose the cardiac monitor most suited for the individual needs of patients.

For more information, visit www.medicompinc.com or call (321) 821-2060.

About Medicomp, Inc.
Founded in 1981, Medicomp designs, develops and provides advanced cardiac monitoring products and services -- including Mobile Cardiac Telemetry, Holter, Event, and AF Burden Monitoring -- utilizing the most sophisticated and reliable ambulatory heart-monitoring systems in the world. Medicomp has been a technology leader in the telemedicine industry. Medicomp is dedicated to research, participating in multiple clinical trials around the globe. Medicomp is led by Dan Balda, M.D. As CEO, he utilizes his medical experience to guide the company with a physician's perspective in caring for patients. For more information, visit www.medicompinc.com.

Media Contact: Danny Condra, Medicomp, Inc., 321-821-2065, dcondra@medicompinc.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Medicomp, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MEDICOMP Medical Awarded GSA Schedule, Will Supply VA Hospitals
2. Sanovas Fills Corporate Bench with Industry Veterans In Clinical, Regulatory and Finance
3. ITelagen Develops Templates for Urologists, Enhancing NextGen Healthcare Electronic Health Record Platform
4. Frost & Sullivan Analyzes Emerging Opportunities for Stakeholders in the Transforming Healthcare Industry
5. Human Circuit Recognized as Industry Leader in Commercial Integrator Magazines Business Series as a Top 5 Healthcare Market Media Integrator for 2013
6. Indonesias Healthcare Reforms Create Opportunities But Also Present New Market Access Hurdles for the Multinational Pharmaceutical Industry
7. Beckers Healthcare Releases Report on State of ASC Industry
8. Strong Sales and Healthcare Reforms Benefit Earnings - Research Report on Gilead, Pfizer, Merck, AbbVie, and LifePoint
9. The Global Healthcare IT Market Report - North America Commands Highest Market Share However Asia-Pacific Set to Have the Highest CAGR
10. Abbott Features Solutions to Help Labs Prepare for the Evolving Healthcare Landscape at the American Association for Clinical Chemistry Lab Expo
11. BioDrain Announces Medical Advisory Board Comprised of Top Doctors and Healthcare Executive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
Breaking Medicine News(10 mins):